These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7268149)

  • 1. [Vasoactive action of glucagon on the portal system. 1. Study on the mesenteric vascular system of the dog].
    de Miguel E; Salgado G; Ginestal JM; Martínez-Veiga JL; Codoceo R; Santamaría L
    Rev Esp Enferm Apar Dig; 1981 Apr; 59(4):441-6. PubMed ID: 7268149
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasoactive action of glucagon on the portal system: II. Study of the hepatic vascular bed in dogs].
    de Miguel E; Ginestal JM; Salgado G; Veiga JL
    Rev Esp Enferm Apar Dig; 1981 Oct; 60(4):357-66. PubMed ID: 7330405
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental study of hyperdynamic vs. stagnant mesenteric blood flow in portal hypertension.
    Witte CL; Witte MH; Bair G; Mobley WP; Morton D
    Ann Surg; 1974 Mar; 179(3):304-10. PubMed ID: 4813477
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamines relax portal and mesenteric veins from normal and portal hypertensive rats.
    Kaumann AJ; Groszmann RJ
    Am J Physiol; 1989 Dec; 257(6 Pt 1):G977-81. PubMed ID: 2575356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of major cations on gastric and mesenteric vascular resistances.
    Texter EC; Laureta HC; Frohlich ED; Chou CC
    Am J Physiol; 1967 Mar; 212(3):569-73. PubMed ID: 6020529
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of glucagon on pressure and oxygen saturation of splanchnic venous blood.
    Jensen HE
    Am J Dig Dis; 1966 Jun; 11(6):447-52. PubMed ID: 5934621
    [No Abstract]   [Full Text] [Related]  

  • 8. Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats.
    Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Chu CJ; Chen CT; Huang HC; Lee SD
    Hepatology; 2001 Apr; 33(4):816-20. PubMed ID: 11283844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of duodenal acidification on gastric circulation and function in the dog.
    Benyó I; Sándor J; Szabó G
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):46-9. PubMed ID: 425803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A COMPARISON OF THE DIRECT EFFECTS OF VASOACTIVE SUBSTANCES ON SEGMENTAL RESISTANCE OF THE MESENTERIC AND PORTAL CIRCULATION OF THE DOG.
    TEXTER EC; MERRILL SL; VANDERSTAPPEN G; CHOU CC; HADDY FJ
    Tijdschr Gastroenterol; 1964; 7():300-11. PubMed ID: 14275794
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of intraportal glucagon on responses of simultaneously perfused hepatic vascular beds of the dog to periarterial nerve stimulation [proceedings].
    Richardson PD; Withrington PG
    J Physiol; 1978 Nov; 284():102P-103P. PubMed ID: 731450
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of glucagon on hepatic blood flow.
    Madding GF; Kennedy PA
    JAMA; 1970 Apr; 212(3):482. PubMed ID: 5467307
    [No Abstract]   [Full Text] [Related]  

  • 14. [Flowmeter changes induced by glucagon in hepato-portal hemodynamics in the course of hemorrhagic shock in dogs].
    Cadili G; Di Gesù G; Di Vita G
    Arch Sci Med (Torino); 1976; 133(1):38-44. PubMed ID: 971078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal venous system measurements in portal hypertension.
    Lafortune M; Marleau D; Breton G; Viallet A; Lavoie P; Huet PM
    Radiology; 1984 Apr; 151(1):27-30. PubMed ID: 6701328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
    Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of the hepatic arterial and portal venous vascular beds of the dog to intra-arterial infusions of noradrenaline and adrenaline: inhibition of the hepatic arterial vasoconstrictor responses by intraportal infusions of glucagon [proceedings].
    Richardson PD; Withrington PG
    Br J Pharmacol; 1979 May; 66(1):82P. PubMed ID: 556185
    [No Abstract]   [Full Text] [Related]  

  • 18. Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats.
    Chang CC; Wang SS; Huang HC; Lee JY; Lee FY; Lin HC; Lee SD
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1394-400. PubMed ID: 20659229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemo-dynamic effects of glucagon in the splanchnic area.
    Jensen HE; Necheles H
    IMJ Ill Med J; 1966 Jul; 130(1):49-53. PubMed ID: 4380243
    [No Abstract]   [Full Text] [Related]  

  • 20. [The echo-Doppler evaluation of the effects of glucagon on the portal flow in normal subjects. The premise for the loading test in portal hypertension].
    Renda F; Olivieri A; Migliorato L; Sanità di Toppi G; Colagrande C
    Radiol Med; 1994 Apr; 87(4):447-51. PubMed ID: 8190928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.